Literature DB >> 8388972

Sequential development of Wilms tumor, T-cell acute lymphoblastic leukemia, medulloblastoma and myeloid leukemia in a child with type 1 neurofibromatosis: a clinical and cytogenetic case report.

G Perilongo1, C A Felix, A T Meadows, P Nowell, J Biegel, B J Lange.   

Abstract

In her 8 1/2 years of life, a girl with neurofibromatosis type 1 (NF1) developed four sequential primary malignant neoplasms: Wilms tumor, T-cell acute lymphoblastic leukemia, medulloblastoma and acute myeloid leukemia. The last three tumors were characterized by chromosomal abnormalities non-randomly associated with that particular disease. There was no evidence of germline p53 mutation or of mutation of p53 in the last two tumors. We hypothesize that an unusual mutation of the NF1 gene in this child promoted growth in tissues where the normal or mutated NF-1 gene product is usually silent or growth inhibitory.

Entities:  

Mesh:

Year:  1993        PMID: 8388972

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  8 in total

Review 1.  Therapy-related myeloid neoplasms: pathobiology and clinical characteristics.

Authors:  H Sill; W Olipitz; A Zebisch; E Schulz; A Wölfler
Journal:  Br J Pharmacol       Date:  2011-02       Impact factor: 8.739

2.  Synchronous Occurance of Acute Myeloid Leukemia and Rhabdomyosarcoma.

Authors:  A V Jayasudha; Rekha A Nair; S Renu; R Binitha; K S Reghu; P Kusumakumary
Journal:  Indian J Hematol Blood Transfus       Date:  2014-11-11       Impact factor: 0.900

3.  Secondary malignant neoplasms after Wilms tumor: an international collaborative study.

Authors:  Norman E Breslow; Jane M Lange; Debra L Friedman; Daniel M Green; Mike M Hawkins; Michael F G Murphy; Joseph P Neglia; Jørgen H Olsen; Susan M Peterson; Charles A Stiller; Leslie L Robison
Journal:  Int J Cancer       Date:  2010-08-01       Impact factor: 7.396

4.  Novel PMS2 pseudogenes can conceal recessive mutations causing a distinctive childhood cancer syndrome.

Authors:  Michel De Vos; Bruce E Hayward; Susan Picton; Eamonn Sheridan; David T Bonthron
Journal:  Am J Hum Genet       Date:  2004-04-07       Impact factor: 11.025

5.  Neurofibromatosis type 1 and high-grade tumors of the central nervous system.

Authors:  Amy Rosenfeld; Robert Listernick; Joel Charrow; Stewart Goldman
Journal:  Childs Nerv Syst       Date:  2009-11-25       Impact factor: 1.475

Review 6.  Constitutional mismatch repair-deficiency syndrome: have we so far seen only the tip of an iceberg?

Authors:  Katharina Wimmer; Julia Etzler
Journal:  Hum Genet       Date:  2008-08-18       Impact factor: 4.132

Review 7.  Acute leukemia following treatment of malignant glioma.

Authors:  J R Perry; M T Brown; J P Gockerman
Journal:  J Neurooncol       Date:  1998-10       Impact factor: 4.130

8.  Prevalence of (Epi)genetic Predisposing Factors in a 5-Year Unselected National Wilms Tumor Cohort: A Comprehensive Clinical and Genomic Characterization.

Authors:  Janna A Hol; Roland P Kuiper; Freerk van Dijk; Esmé Waanders; Sophie E van Peer; Marco J Koudijs; Reno Bladergroen; Simon V van Reijmersdal; Lionel M Morgado; Jet Bliek; Maria Paola Lombardi; Saskia Hopman; Jarno Drost; Ronald R de Krijger; Marry M van den Heuvel-Eibrink; Marjolijn C J Jongmans
Journal:  J Clin Oncol       Date:  2022-03-01       Impact factor: 50.717

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.